Deciding Whether to Stop Cancer Treatment

There is no medical rule that says a person must keep taking treatment. There is also no rule that says they must stop.

Both directions are legitimate. What makes one right is not courage or realism. It is fit: does this treatment buy the kind of time this person wants, at a cost they are willing to pay?

NCI is direct about the framing. "Choosing hospice care doesn't mean that you've given up hope. Instead, hospice care means you're changing what you hope for."

It does not mean stopping care. NCI describes what happens when cancer can no longer be controlled: "medical testing and cancer treatment often stop. But the person's care continues, with an emphasis on improving their quality of life."

None of this is automatically switched off when anticancer treatment stops. What you actually get depends on your goals, on what would genuinely help you, and on what your local services and your cover provide, so ask what stays in place for you.

• Pain and symptom medicines.
• Scans and tests done for comfort reasons, such as checking a blockage.
• Radiotherapy given to shrink a painful deposit.
• Fluid drained from the abdomen or chest.
• Home nursing, equipment, and oxygen.
• Your oncologist, who does not simply discharge you, though who leads your care can shift towards palliative care or your family doctor.

Stopping treatment is a decision about one category of drug. It is not a decision to be left alone.

NCI lists several paths, and more than one can run at the same time.

Keep treating. Some people want more active treatment, weighing "risks and benefits of available treatments."

An early-phase trial. NCI is honest about the odds: "the chance that the new treatment will benefit a patient in such a trial is low." Some people join anyway, hoping to slow growth, or wanting to contribute something. Both are reasonable motives, as long as the odds are named.

Palliative care. NCI defines it as "care that makes patients feel better but doesn't treat the disease itself," and notes that it "continues through treatment and beyond." You do not have to stop treatment to have it. Ask for it now.

Hospice. NCI describes it as care in which "medical, psychological, and spiritual support are given," along with counseling and respite care.

Stop active treatment, keep supportive care. NCI describes this as choosing not to pursue "more active cancer treatment" while continuing "supportive care in order to keep you as comfortable as possible."

Treatment sometimes works better than expected. Some cancers respond to third and fourth lines. Newer immunotherapies produce long responses in a minority of people, and nobody can point out in advance who that minority will be.

There are also non-medical reasons that are perfectly valid. A wedding in four months. A grandchild due in the spring. Wanting to be able to say you tried everything. Wanting your children to see you fight.

Continuing is not denial. It is a bet placed with open eyes, and it is yours to place.

Treatment has a price, and it is paid in the currency of time and function.

Days spent in infusion chairs, in waiting rooms, and in bed recovering are days not spent elsewhere. Side effects can take away the things that made the extra time worth having. And a treatment that is not working is causing harm without buying anything.

There is a pattern in the data worth knowing. NCI reports that "increasing numbers of patients start a new chemotherapy regimen within 30 days of death or continue to receive chemotherapy within 14 days of death." Chemotherapy given in the final fortnight is not usually a plan anyone chose on purpose. It is what happens when the conversation keeps getting postponed.

Stopping is not giving up. For many people it is the point at which they finally get to decide how the remaining time is spent.

Many people are never asked whether they want to know. NCI cites a study of newly diagnosed advanced lung cancer patients in which 88.2 percent wanted information about life expectancy, but only 52.7 percent said they received it. Strikingly, "none of the patients recalled being asked about their information preferences."

So say it first. Try: "I want numbers, even rough ones," or "I do not want numbers, but I want my daughter to have them."

Then ask for the three-part answer:

• If this treatment works as well as it possibly could, what does that look like?
• If it goes badly, what does that look like?
• What usually happens?

Ask what happens with no further anticancer treatment, too. That is the comparison the decision actually turns on, and it rarely gets stated out loud.

People systematically expect more than treatment delivers. NCI reports that patients who estimated they had a 90 percent or better chance of surviving six months were more likely to prefer life-extending therapy, and more likely to experience a readmission, attempted resuscitation, or death on a ventilator.

That is not stupidity. Hope is doing its job. But it means the honest question to put to your oncologist is not "is there anything else?" There is almost always something else. The question is: "What would this add, in weeks or months, and what would it cost me in how I feel?"

Oncologists use performance status, a rating of how much of the day a person can spend up and active. It predicts both how well treatment is tolerated and how much it is likely to help. NCI notes that better functional status goes with better quality of life.

If someone is spending most of the day in bed, that is clinical information, not a mood. Report it accurately, even if it feels like conceding something. Overstating function to qualify for treatment is a common and understandable instinct, and it can lead to treatment that harms.

NCI also observes that patients with poor performance status were more likely to prefer a passive role in decisions. If you are the family member, notice that. Being tired is not the same as not caring what happens.

Hospice is not for the final week, although that is how it often gets used.

NCI explains the eligibility rule: patients "usually qualify for hospice when their doctor signs a statement saying that patients with their type and stage of disease, on average, aren't likely to survive beyond 6 months," and that Medicare hospice "can be used as much as 6 months before death is anticipated."

Six months. Yet NCI reports that hospice length of stay "remains relatively brief," with a concerning share of stays under seven days. A week is not enough time for hospice to do what it does well.

None of it is a one-way door. People leave hospice if they improve, and can re-elect it later. Coming off hospice to have a treatment and going back on is possible, but it is a formal revocation and re-election rather than a pause, and it can affect what is covered in between, so ask the hospice team to walk you through exactly how it works before you rely on it.

Ask these, in this order.

1. Is this treatment working? What are you measuring to decide that?
2. If we continue, what do you expect to change, and by how much?
3. If we stop anticancer treatment, what happens, and how quickly?
4. What symptoms would you be treating either way?
5. Can we start palliative care now, alongside whatever we choose?
6. What would make you tell me it is time to stop?

That last question is the useful one. Ask the oncologist to name the trigger in advance. It turns a frightening open question into a specific one you can revisit.

NCI notes that when patients discuss their care options with a doctor early, stress falls and their ability to cope rises. Having the conversation early costs nothing and does not commit you to anything.

• Choices for Care When Treatment May Not Be an Option — National Cancer Institute
• End-of-Life Care for People Who Have Cancer — National Cancer Institute
• Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ) — Health Professional Version — National Cancer Institute